OVERVIEW
Testicular Carcinoma Testicular carcinoma is a type of cancer that develops in the testicles, the male reproductive glands responsible for producing sperm and testosterone. It is one of the most common cancers in young and middle-aged men but has a high survival rate when detected early. The two primary types of testicular carcinoma are seminomas, which grow slowly and respond well to treatment, and non-seminomas, which are more aggressive. Risk factors include a family history of testicular cancer, undescended testicles (cryptorchidism), and certain genetic conditions. Symptoms may include a painless lump, swelling, or discomfort in the testicle. Early diagnosis and treatment, including surgery, radiation, or chemotherapy, are essential for a successful outcome.
Testicular carcinoma, or testicular cancer, is a malignancy that originates in the testicles (testes), which are part of the male reproductive system. It is most commonly diagnosed in young men between the ages of 15 and 35 but can occur at any age. Testicular cancer is highly treatable, especially when detected early.
Causes
The exact cause of testicular cancer is not fully understood, but it occurs when healthy cells in the testicles become altered, leading to uncontrolled cell growth and tumor formation. The majority of testicular cancers are germ cell tumors (GCTs), which are divided into two main types:
1. Seminomas: Slow-growing and generally more responsive to radiation therapy.
2. Non-seminomas: More aggressive, can spread faster, and often require chemotherapy.
Risk Factors
• Undescended testicle (cryptorchidism): Men born with one or both testicles that did not descend into the scrotum have a higher risk, even if the condition is surgically corrected.
• Family history: Having a father or brother with testicular cancer increases risk.
• Personal history: Men who have had testicular cancer in one testicle are at increased risk of developing it in the other testicle.
• Age: Most common in young men between 15 and 35 years old.
• Race/ethnicity: Testicular cancer is more common in White men compared to men of other races.
• Abnormal testicle development: Conditions like Klinefelter syndrome increase risk.
• HIV infection: Men with HIV, particularly those with AIDS, have an increased risk.
Signs and Symptoms
• Lump or swelling in the testicle: The most common symptom is a painless lump or swelling in one testicle. It may be discovered by the patient or during a routine examination.
• Testicular pain or discomfort: Pain or discomfort in the scrotum or lower abdomen can sometimes occur.
• Heavy feeling in the scrotum: A sensation of heaviness or fluid buildup (hydrocele) in the scrotum.
• Back pain: Advanced cases can present with lower back pain due to the spread of cancer to the lymph nodes.
• Gynecomastia: Breast tenderness or enlargement due to hormone changes from certain testicular tumors.
• Signs of metastasis: If the cancer spreads, symptoms such as cough, shortness of breath, or abdominal pain can develop.
Laboratory Investigations and Findings
1. Tumor Markers: Blood tests to measure certain proteins that may be elevated in testicular cancer:
• Alpha-fetoprotein (AFP): Elevated in non-seminomas but not in pure seminomas.
• Human chorionic gonadotropin (hCG): Elevated in both seminomas and non-seminomas.
• Lactate dehydrogenase (LDH): Elevated in some cases and can indicate tumor burden.
2. Ultrasound of the Testicles: The first imaging test performed to evaluate a suspicious mass. It helps differentiate between solid tumors and benign conditions like cysts or infections.
3. Computed Tomography (CT) Scan: Used to assess whether the cancer has spread to the abdomen, pelvis, or chest, especially to the lymph nodes.
4. Chest X-ray or CT Scan of the Chest: To check for metastasis to the lungs.
5. Radical Inguinal Orchiectomy: Surgical removal of the affected testicle is both a diagnostic and therapeutic procedure. The removed tissue is examined histologically to confirm the type and stage of cancer.
6. Magnetic Resonance Imaging (MRI): May be used in specific cases for a more detailed view, especially if metastasis is suspected.
Staging
Staging is based on the extent of cancer spread:
• Stage I: Cancer is confined to the testicle.
• Stage II: Cancer has spread to lymph nodes in the abdomen.
• Stage III: Cancer has spread to other parts of the body, such as the lungs or liver.
Treatment
The treatment plan depends on the type and stage of testicular cancer. The three main treatment modalities are surgery, radiation, and chemotherapy.
1. Surgery
• Radical Inguinal Orchiectomy: The primary treatment for almost all stages and types of testicular cancer. The entire testicle and spermatic cord are removed through an incision in the groin.
• Retroperitoneal Lymph Node Dissection (RPLND): Surgical removal of lymph nodes in the abdomen to treat or prevent the spread of cancer.
2. Radiation Therapy
• Seminomas: Respond well to radiation, especially for early-stage (Stage I and II) seminomas. It is often used to treat cancer that has spread to nearby lymph nodes.
• Non-seminomas: Typically not treated with radiation as they are less responsive.
3. Chemotherapy
• Non-seminomas: More aggressive tumors often require chemotherapy. Commonly used drugs include cisplatin, etoposide, and bleomycin (BEP regimen).
• Advanced seminomas: Chemotherapy may also be used if the cancer has spread beyond the lymph nodes or does not respond to radiation.
• High-risk and metastatic cases: Chemotherapy is usually recommended for more advanced stages of testicular cancer.
4. Surveillance
• For some early-stage testicular cancers (especially seminomas), after orchiectomy, doctors may recommend regular surveillance (checkups with periodic CT scans and blood tests) rather than immediate additional treatment.
5. Stem Cell Transplant
• In rare cases of recurrent or resistant testicular cancer, high-dose chemotherapy followed by a stem cell transplant may be considered.
Follow-up and Prognosis
• Regular follow-up: Involves monitoring tumor markers, imaging tests, and physical exams to detect recurrence. • Prognosis: Testicular cancer has a very high cure rate, with over 95% of men surviving at least five years after diagnosis, especially when caught early. Even in advanced cases, aggressive treatment often leads to remission.